Read more at CNBC.
Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy
Date: |
Sort by
Filter
Date
Items per page
-
American Airlines’ stock jumps after an upbeat profit outlook and record revenue
American Airlines’ stock climbed Thursday, after the air carrier reported a wider-than-expected loss but provided an upbeat profit outlook for the current quarter, as revenue rose to record levelsMarketWatch - Business -
Gilead’s quarterly loss is narrower than expected
Gilead Sciences Inc.’s stock dipped 0.2% in after-hours trading Thursday, after the drug company’s adjusted first-quarter profit was narrower than expected.MarketWatch - Business -
Meta plunges 16% on weak revenue guidance even as first-quarter results top estimates
Meta beat on the top and bottom lines in its earnings report on Wednesday, but the stock sank on disappointing guidance.CNBC - Business -
AMC takes a hit from Hollywood strikes, but narrows quarterly loss
AMC reported preliminary first-quarter earnings late Friday, ahead of expectations that it would report the results early next month.MarketWatch - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
European commercial real estate deal making slumps to 13-year low
Seventh successive quarter of declining volumes dashes hopes for revival as high interest rates continue to biteFinancial Times - Business - Europe -
Is Britain suffering from a ‘sick note culture’?
Rishi Sunak has vowed to get people back to work but data indicates problems with the diagnosis — and proposed solutionFinancial Times - Business - United Kingdom
More from CNBC
-
All the data so far is showing inflation isn't going away, and is making things tough on the Fed
The last batch of inflation news that Federal Reserve officials will see before their meeting next week is in, and none of it is very good.CNBC - Business -
Federal regulator finds Tesla Autopilot has 'critical safety gap' linked to hundreds of collisions
Federal authorities say a "critical safety gap" in Tesla's Autopilot system contributed to at least 467 collisions, 13 resulting in fatalities.CNBC - Business - Tesla -
Intel used to dominate the U.S. chip industry. Now it's struggling to stay relevant
Intel has missed most of the significant technology transitions over the past 15-plus years, losing its standing in the chip industry along the way.CNBC - Business -
American Airlines cuts some international flights into 2025, citing Boeing delivery delays
American is the latest carrier to tweak its growth plan, citing late-arriving planes from Boeing.CNBC - Business - Travel -
Alphabet soars most since 2015 on strong earnings, first dividend and $70 billion buyback
Alphabet shares shot up Friday after the company posted better-than-expected first-quarter results and greenlit its first-ever dividend along with a buyback.CNBC - Business